Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 10.88 GBp
Change Today 0.00 / 0.00%
Volume 39.2K
LID On Other Exchanges
Symbol
Exchange
OTC US
London
Frankfurt
As of 11:30 AM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

lidco group plc (LID) Snapshot

Open
10.88 GBp
Previous Close
10.88 GBp
Day High
10.88 GBp
Day Low
10.88 GBp
52 Week High
07/8/14 - 17.75 GBp
52 Week Low
02/11/15 - 5.38 GBp
Market Cap
21.1M
Average Volume 10 Days
21.5K
EPS TTM
0.0017 GBp
Shares Outstanding
194.2M
EX-Date
--
P/E TM
64.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for LIDCO GROUP PLC (LID)

Related News

No related news articles were found.

lidco group plc (LID) Related Businessweek News

No Related Businessweek News Found

lidco group plc (LID) Details

LiDCO Group Plc develops, manufactures, and sells cardiac monitoring equipment in the United Kingdom, the United States, Continental Europe, Japan, and internationally. It offers LiDCOplus, a computer-based platform monitor, which is used in the intensive care unit for real-time continuous display of hemodynamic parameters, such as cardiac output, oxygen delivery, and fluid-volume responsiveness; and LiDCOrapid, a cardiac output monitor for use in the operating theatre and peri-operative arenas for fluid and drug management. The company also provides LiDCOview, an easy-to-use graphical display of historical hemodynamic data that is used for research and education purposes; LiDCOrapidv2 with Unity software, which is designed for multi-parameter monitoring of anesthesia and fluids; and surgical disposables. LiDCO Group Plc sells its products through direct sales and a network of distributors, as well as licensing. The company was founded in 1991 and is headquartered in London, the United Kingdom.

50 Employees
Last Reported Date: 04/1/15
Founded in 1991

lidco group plc (LID) Top Compensated Officers

Co-Founder, Chief Executive Officer, Executiv...
Total Annual Compensation: 221.0K GBP
Co-Founder and Member of Clinical Advisory Bo...
Total Annual Compensation: --
Finance Director and Executive Director
Total Annual Compensation: 159.0K GBP
Compensation as of Fiscal Year 2015.

lidco group plc (LID) Key Developments

LiDCO Group plc Announces Appointment of Matthew Sassone as Board of Director

LiDCO Group plc announced that the appointment of Matthew (Matt) Sassone to the Board as a director has now taken effect. Initially Matt will take on the role of Chief Executive Officer Designate, becoming Chief Executive Officer following a handover period with Dr. Terry O'Brien, who is expected to retire at the close of business on 14 August 2015.

LiDCO Group Announces Reimbursement Approval in Japan for LiDCOrapid v2 Disposables

LiDCO Group Plc announced that approval has been obtained for reimbursement in Japan of its single patient disposable kit (which contains an Argon pressure transducer and a LiDCO Smart Card) with effect from the beginning of June 2015. This reimbursement follows Japanese product approval for the LiDCOrapidv2 with Unity software and continuous non-invasive blood pressure module announced in March 2015. LiDCO's single patient disposable kit will be reimbursed at the same rate as the existing disposable product for arterial line minimally invasive hemodynamic monitoring in the Japanese market, while offering Japanese customers the option of the additional parameter of continuous non-invasive blood pressure.

LiDCO Group plc Announces Management Changes

LiDCO Group plc announced that Matthew (Matt) Sassone has agreed to join the Board as Chief Executive Officer. He will take up his appointment with effect from June 15, 2015, initially as director and Chief Executive Officer Designate, whilst he works with Dr. Terry O'Brien, the current Chief Executive Officer, in respect of the handover of his duties. Terry O'Brien (CEO and LiDCO's founder) will retire from his Board position and role as CEO of LiDCO following a period where he will work alongside Matt to ensure a smooth handover. Terry's retirement and Matt's appointment as CEO are expected to take place on the 17 August 2015. Mr. Sassone has over 18 years' experience in the medical industry having started his career in sales for Quintiles in 1996. Mr. Sassone is he is currently Chief Marketing Officer of Maquet.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LID:LN 10.88 GBp 0.00

LID Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Deltex Medical Group PLC 6.00 GBp +0.25
Edwards Lifesciences Corp $147.48 USD +2.36
Hospira Inc $89.20 USD +0.20
ICU Medical Inc $96.22 USD -0.91
Masimo Corp $38.57 USD +0.09
View Industry Companies
 

Industry Analysis

LID

Industry Average

Valuation LID Industry Range
Price/Earnings 63.8x
Price/Sales 2.6x
Price/Book 2.8x
Price/Cash Flow 30.1x
TEV/Sales 2.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIDCO GROUP PLC, please visit www.lidco.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.